Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 08:39 am Purchase | 2025-03-31 | 13G | 89BIO INC ETNB | Deep Track Capital LP | 13,816,333 9.180% | 7,338,384 (+113.28%) | Filing History |
| 2025-05-15 08:38 am Unchanged | 2025-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Deep Track Capital LP | 7,419,355 8.270% | 0 (Unchanged) | Filing History |
| 2025-05-15 08:37 am Sale | 2025-03-31 | 13G | BICYCLE THERAPEUTICS PLC SPONS BCYC | Deep Track Capital LP | 2,821,171 5.670% | -509,065 (-15.29%) | Filing History |
| 2025-05-15 08:36 am Purchase | 2025-03-31 | 13G | ALLAKOS INC ALLK | Deep Track Capital LP | 7,232,701 8.020% | 4,721,965 (+188.07%) | Filing History |
| 2025-05-13 4:32 pm Purchase | 2025-05-06 | 13G | ORUKA THERAPEUTICS INC ORKA | Deep Track Capital LP | 1,896,780 5.070% | 1,896,780 (New Position) | Filing History |
| 2025-04-10 4:14 pm Purchase | 2025-04-03 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Deep Track Capital LP | 3,250,000 5.290% | 3,250,000 (New Position) | Filing History |
| 2025-03-26 4:09 pm Purchase | 2025-03-19 | 13G | IMMUNOVANT INC IMVT | Deep Track Capital LP | 9,500,000 5.590% | 8,500,000 (+850.00%) | Filing History |
| 2025-03-25 4:06 pm Purchase | 2025-03-18 | 13G | GERON CORP GERN | Deep Track Capital LP | 35,000,000 5.500% | 27,424,951 (+362.04%) | Filing History |
| 2025-03-24 4:08 pm Sale | 2025-03-17 | 13G | DIANTHUS THERAPEUTICS INC DNTH | Deep Track Capital LP | 2,357,702 7.340% | -642,298 (-21.41%) | Filing History |
| 2025-02-19 9:51 pm Unchanged | 2025-02-18 | 13D | DYNAVAX TECHNOLOGIES CORP COM DVAX | Deep Track Capital LP | 17,791,486 13.500% | 0 (Unchanged) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2025-02-07 | 13G | IKENA ONCOLOGY INC IKNA | Deep Track Capital LP | 209,626 5.210% | 209,626 (New Position) | Filing History |
| 2025-02-14 4:31 pm Purchase | 2025-02-07 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital LP | 4,125,000 5.440% | 1,125,000 (+37.50%) | Filing History |
| 2025-02-14 08:48 am Sale | 2024-12-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Deep Track Capital LP | 523,989 4.140% | -136,147 (-20.62%) | Filing History |
| 2025-02-14 08:48 am Sale | 2024-12-31 | 13G | PYXIS ONCOLOGY INC PYXS | Deep Track Capital LP | 0 0.000% | -4,184,100 (Position Closed) | Filing History |
| 2025-02-14 08:46 am Purchase | 2024-12-31 | 13G | ENGENE HLDGS INC ENGN | Deep Track Capital LP | 4,557,575 8.940% | 2,307,575 (+102.56%) | Filing History |
| 2025-02-14 08:45 am Sale | 2024-12-31 | 13G | EDITAS MEDICINE INC EDIT | Deep Track Capital LP | 0 0.000% | -5,473,086 (Position Closed) | Filing History |
| 2025-02-14 08:44 am Sale | 2024-12-31 | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | Deep Track Capital LP | 3,460,756 4.650% | -602,920 (-14.84%) | Filing History |
| 2025-02-14 08:43 am Sale | 2024-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | Deep Track Capital LP | 131,733 1.070% | -929,777 (-87.59%) | Filing History |
| 2025-02-14 08:42 am Purchase | 2024-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital LP | 3,000,000 4.240% | 2,170 (+0.07%) | Filing History |
| 2025-02-14 08:41 am Sale | 2024-12-31 | 13G | SYROS PHARMACEUTICALS INC SYRS | Deep Track Capital LP | 0 0.000% | -699,281 (Position Closed) | Filing History |